[Double-blind study on piribedil in peripheral arterial diseases].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010879:Piperazines / Q000627:therapeutic use*; D010891:Piribedil / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced
D010879:Piperazines; D010891:Piribedil
Studio in doppio cieco del piribedil nelle arteriopatie periferiche